ONA strongly criticized the Trump administration's decision to dissolve the CDC Healthcare Infection Control Practices ...

A recent study from a team of researchers, including those from UC San Diego, gives new credence to the theory that the COVID ...

Learn more about whether Moderna, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or Moderna, Inc. is a better investment based on AAII's A+ Investor ...

Moderna’s study, involving 8,000 adults 50 and older, showed the new combo shot generated an immune response against COVID and most strains of flu compared to existing stand-alone shots.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The knowledge of the vaccine and its eligibility is limited.

It also found RSV patients had higher ICU admission rates than COVID-19 patients with updated vaccines. RSV, often assumed to be a childhood illness, is a significant threat to seniors and those ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

“Maintaining availability of high quality COVID-19 vaccines is critical. However, widespread use of the vaccine by the general public will likely not be needed.” RSV is a common respiratory virus that ...

The Trump administration’s new COVID-19 website draws attention to five points suggesting that the virus likely originated inside the Wuhan Institute of Virology in China, rather than any ...